KOLLTAN PHARMACEUTICALS INC of NEW HAVEN, CT, a company, filed a Form D exempt-offering notice with the SEC on 2014-03-19. The offering totals $60.0M, of which $60.0M was reported sold. Industry: Biotechnology.
Showing 25 of 31 people.
| Name | Role | Location |
|---|---|---|
| Arthur G Altschul, Jr. | Director | New Haven, CT |
| Axel G Bolte | Director | New Haven, CT |
| K. Peter Hirth | Director | South San Francisco, CA |
| Gerald McMahon | Director | South San Francisco, CA |
| Paul Jonathan Medeiros | Director | New Haven, CT |
| Thomas B Neff | Director | San Francisco, CA |
| Joseph B Schlessinger | Director | New Haven, CT |
| E. Jonathan Soderstrom | Director | New Haven, CT |
| Stanley Pritchett Choy | Executive Officer | New Haven, CT |
| Yaron Pritchett Hadari | Executive Officer | New Haven, CT |
| Jane Pritchett Henderson | Executive Officer | New York, NY |
| Theresa M LaVallee | Executive Officer | New Haven, CT |
| Gerald McMahon | Executive Officer | South San Francisco, CA |
| Carolyn F Sidor | Executive Officer | New Haven, CT |
| Peter Hirth | Director | South San Francisco, CA |
| W. Bradford Middlekauff | Executive Officer | Exton, PA |
| Joseph Schlessinger | Director | Woodbridge, CT |
| Joseph Schlessinger | Promoter | Woodbridge, CT |
| Axel Bolte | Director | Boston, MA |
| Arthur G Altschul, Jr. | Executive Officer | New Haven, CT |
| Arthur G Altschul, Jr. | Promoter | New Haven, CT |
| Stanley Jonathan Choy | Executive Officer | New Haven, CT |
| Yaron Jonathan Hadari | Executive Officer | New Haven, CT |
| Michael Schmertzler | Director | New Haven, CT |
| Michael Schmertzler | Executive Officer | New Haven, CT |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2012-03-07 | D | $25.0M | $25.0M |
| 2010-09-16 | D/A | $7.5M | $6.0M |
| 2010-01-04 | D | $2.5M | $2.5M |
| 2009-09-08 | D | $7.5M | $3.5M |
| 2009-08-12 | D/A | $40.0M | $40.0M |